Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of mA Regulators in Pancreatic Cancer.

N-methyladenosine (mA) modification may modulate various biological processes. Nonetheless, clinical implications of mA modification in pancreatic cancer are undefined. Herein, this study comprehensively characterized the mA modification patterns in pancreatic cancer based on mA regulators.